treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra...) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis...
institution, with documentation in two or more of the following: In-field national, regional, or state professional... certification (national, regional, or state) in business related field (does not to include a teaching license or certificate...
Job Level: F2 Duke is an Equal Opportunity Employer committed to providing employment opportunity without regard... to an individual's age, color, disability, gender, gender expression, gender identity, genetic information, national origin, race...
. Distinguishing Characteristics of this Level N/A Job Code: 00005028 CLINICAL SOCIAL WORKER Job Level: F2 Duke..., color, disability, gender, gender expression, gender identity, genetic information, national origin, race, religion, sex...
. Distinguishing Characteristics of this Level N/A BEHAVIORAL HEALTH THERAPIST Job Level: F2 Duke is an Equal Opportunity... expression, gender identity, genetic information, national origin, race, religion, sex (including pregnancy and pregnancy related...
departmental, hospital and/or DUHS initiatives. Distinguishing Characteristics of this Level N/A Job Level: F2 Duke..., color, disability, gender, gender expression, gender identity, genetic information, national origin, race, religion, sex...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... consideration for employment without regard to race, ethnicity, color, religion, sex gender identity, sexual orientation, national...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra..., sexual orientation, national origin, age, disability, protected veteran or disabled status, or other characteristic protected...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase...
treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra... for employment without regard to race, ethnicity, color, religion, sex gender identity, sexual orientation, national origin, age...